Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Total Assignments:
4
|
|
Patent #:
|
|
Issue Dt:
|
04/02/2019
|
Application #:
|
15719821
|
Filing Dt:
|
09/29/2017
|
|
Publication #:
|
|
Pub Dt:
|
10/25/2018
| | | | |
|
Inventors:
|
Ante Tocilj, Jack Coleman, Elazar Rabbani, James J. Donegan
|
|
Title:
|
Immunomodulatory Pharmaceutical Compositions and Methods of Use Thereof
|
|
|
Assignment:
1
|
|
|
|
|
|
|
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
|
|
|
| 527 MADISON AVENUE |
| NEW YORK, NEW YORK 10022 |
|
|
|
|
| ENZO BIOCHEM, INC. |
| 527 MADISON AVENUE |
| NEW YORK, NY 10022 |
|
|
|
Assignment:
2
|
|
|
|
|
|
|
CORRECTIVE ASSIGNMENT TO CORRECT THE CITIZENSHIP OF INVENTOR ANTE TOCILJ FROM U.S. TO CANADA PREVIOUSLY RECORDED ON REEL 043880 FRAME 0229. ASSIGNOR(S) HEREBY CONFIRMS THE CITIZENSHIP OF INVENTOR ANTE TOCILJ FROM U.S. TO CANADA.
|
|
|
|
|
|
|
|
|
| 527 MADISON AVENUE |
| NEW YORK, NEW YORK 10022 |
|
|
|
|
| ENZO BIOCHEM, INC. |
| 527 MADISON AVENUE |
| NEW YORK, NY 10022 |
|
|
|
Assignment:
3
|
|
|
|
|
|
|
SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
|
|
|
| ONE INTERNATIONAL PLAZA, SUITE 220 |
| PHILADELPHIA, PENNSYLVANIA 19113 |
|
|
|
|
| N. PAUL COYLE |
| 190 S LASALLE ST STE 3700 |
| DUANE MORRIS LLP |
| CHICAGO, IL 60603 |
|
|
|
Assignment:
4
|
|
|
|
|
|
|
RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
|
|
|
| 81 EXECUTIVE BLVD., SUITE 3 |
| FARMINGDALE, NEW YORK 11735 |
|
|
|
| 81 EXECUTIVE BLVD., SUITE 3 |
| FARMINGDALE, NEW YORK 11735 |
|
|
|
| 10 EXECUTIVE BLVD. |
| FARMINGDALE, NEW YORK 11735 |
|
|
|
| 10 EXECUTIVE BLVD. |
| FARMINGDALE, NEW YORK 11735 |
|
|
|
|
| EDWARD A. GORDON |
| MCDERMOTT WILL & EMERY LLP |
| 200 CLARENDON STREET, FLOOR 58 |
| BOSTON, MA 02116-5021 |
|
|
Search Results as of:
05/24/2024 10:37 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
